Skip to search formSkip to main contentSkip to account menu

RP 59500

Known as: RP-59500 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1995
Highly Cited
1995
RP 59500 is a new injectable streptogramin composed of two synergistic components (quinupristin and dalfopristin) which are… 
Review
1995
Review
1995
Objective: To review the current knowledge on RP 59500 (quinupristin/dalfopristin, Synercid), a new streptogramin antibiotic… 
Highly Cited
1994
Highly Cited
1994
Time-kill studies were used to examine the in vitro activities of penicillin G, RP 59500, erythromycin, ciprofloxacin… 
Highly Cited
1992
Highly Cited
1992
RP 59500 is a combination of RP 57669 and RP 54476, which are semisynthetic water soluble derivatives of pristinamycin IA (PIA… 
Highly Cited
1992
Highly Cited
1992
The MICs of four new quinolones, sparfloxacin (AT-4140, CI-978), PD 131628 (the active form of the prodrug CI-990), temafloxacin… 
Highly Cited
1992
Highly Cited
1992
The tolerance and pharmacokinetic behaviour of a new injectable streptogramin antibiotic, RP 59500 were evaluated on 26 healthy… 
1992
1992
The post-antibiotic effect (PAE) of the semisynthetic streptogramin RP 59500 was evaluated with four clinical isolates of… 
Highly Cited
1992
Highly Cited
1992
RP 59500 is a semisynthetic streptogramin (Sg) composed of two synergic components: RP 57669 and RP 54476. The activities of RP… 
Highly Cited
1992
Highly Cited
1992
RP 59500 is a 30:70 mixture of RP 57669 and RP 54476. The activity of RP 59500 and its two components against Gram-positive and… 
Highly Cited
1991
Highly Cited
1991
  • R. Fass
  • Antimicrobial Agents and Chemotherapy
  • 1991
  • Corpus ID: 12528756
The in vitro activity of RP 59500, a semisynthetic pristinamycin, was compared with the activities of vancomycin, oxacillin…